January 23, 2018
Several of the firm’s biotech holdings tripled in value in 2017, leading to a third 40-plus percent return in five years.
Over the past five years, hedge fund manager Joseph Edelman has had one of the hottest hands in the industry. In 2017, he achieved a return above 40 percent for the third time during this period. And unlike many other …
*free trial allows access to online content excluding research, rankings and data.
Subscribers have unlimited access to all online content inc rankings. Start your subscription today - click on the button below.
Taking a free trial will give you access to online content one week (excludes research & rankings). Start your trial today.
How will hedge funds finish 2017?
View previous results
All material subject to strictly enforced copyright laws. ©
Euromoney Institutional Investor PLC.
Sorry, you are not allowed to print this article.
Please contact us if you have any inquiry.